Skip to main content
Log in

Quality-of-life assessment in cancer clinical trials: an intervention by itself?

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Feasibility issues of quality-of-life (QL) assessment in cancer clinical trials have been discussed mainly in regard to compliance with QL questionnaires. In the case of an acceptable compliance, it is usually taken for granted that questionnaires received at the office for central data management have been filled in according to the rules and guidelines stated in the study protocol. The question whether local conditions of data collection might have a substantial influence on patients' QL estimation is not considered. In clinical experience, QL assessment in cancer patients may be a supportive intervention by itself, increasing awareness to QL issues in both patients and staff. To elaborate further on this question and the potentially interfering effects on patients' self-estimation we asked the nurses involved in the QL assessment of a randomized trial in small-cell lung cancer to describe their experiences. Meetings between the nurses collecting the data and the study coordinator took place on a regular basis. The detailed protocols of these meetings are used to describe qualitatively the possible influence of such unsystematically assessed factors on compliance and data quality. Implications regarding QL methodology are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aaronson NK (1992) The quality of life of patients in cancer clinical trials: common problems and common sense solutions. Eur J Cancer 28:1304–1307

    Google Scholar 

  2. Aaronson NK, Bakker W, Stewart AL, et al (1987) Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson NK, Beckmann J (eds) The quality of life of cancer patients. Raven Press, New York, pp 101–109

    Google Scholar 

  3. Bernhard J (1992) “Lebensqualität” in onkologischen Therapiestudien. Konzepte, Methodik und Anwendung am Beispiel des kleinzelligen Bronchuskarzinoms. Lang, Bern Frankfurt a M New York

    Google Scholar 

  4. Breetvelt IS, Dam FS van (1991) Underreporting by cancer patients: the case of response-shift. Soc Sci Med 32:981–987

    Google Scholar 

  5. Deyo RA, Diehr P, Patrick DL (1991) Reproductibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clin Trials 12 [Suppl]:142–158

    Google Scholar 

  6. Greenberg ER, Chute CG, Stukel T, et al (1988) Social and economic factors in the choice of lung cancer treatment: a population-based study in two rural states. N Engl J Med 318:612–617

    Google Scholar 

  7. Hürny C, Piasetsky E, Bagin R, Holland JC (1987) High social desirability in patients being treated for advanced colorectal and bladder cancer. J Psychosoc Oncol 5:19–29

    Google Scholar 

  8. Hürny C, Bernhard J, Joss R, et al, for the Swiss Group for Clinical Cancer Research (1992) Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer. A lesson from the real world. Ann Oncol 3:825–831

    Google Scholar 

  9. Richardson JL, Marks G, Levine A (1988) The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 6:1746–1752

    Google Scholar 

  10. Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ (1982) Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91:17–23

    Google Scholar 

  11. Zerssen D von (1986) Clinical selfrating scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS München). In: Sartorius N, Ban TA (eds) Assessment of depression. Springer, Berlin Heidelberg New York, pp 270–303

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernhard, J., Gusset, H. & Hürny, C. Quality-of-life assessment in cancer clinical trials: an intervention by itself?. Support Care Cancer 3, 66–71 (1995). https://doi.org/10.1007/BF00343923

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00343923

Key words

Navigation